SlideShare a Scribd company logo
20152015
EDC and eCOA/ePRO
Market Dynamics
and Service Provider
Performance (2015)
Info@ISRreports.com 	 	
	
©2015 Industry Standard Research www.ISRreports.com
PREVIEW
www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 2
act with confidence
Report Overview
This report examines the industry perception of the EDC and eCOA/ePRO markets based on
the responses of over 150 industry professionals experienced with these systems. ISR has asked
respondents how their respective companies handle the decisions associated with outsourcing
these systems as well as how they would prefer the outsourcing be handled. Additionally, ISR has
benchmarked 22 EDC and 22 eCOA/ePRO systems based on 651 EDC and 432 ePRO service provider
encounters. Each provider’s performance is evaluated and benchmarked based on the performance of
these providers against expectations across 18-21 attributes.
166Respondents
136Pages
121Charts and Graphs
Q2,
2015
Publication Date
1.	 Executive Summary: In this section, ISR summarizes the key findings found throughout the
report. The majority of these data are examined in more detail in the subsequent sections.
2.	 EDC Market Environment: Examines how respondents’ companies are utilizing EDC
systems, how these systems are impacting clinical trial activity, and how they could see
these systems improved moving forward.
3.	 EDC Provider Selection Criteria: Outlines the criteria by which sponsors and CROs select
service providers for EDC-related services as well as respondents’ preferences for specific
EDC platforms.
4.	 EDC Service Provider Performance: Evaluates the performance of 22 different EDC service
providers across 18 different performance attributes.
5.	 eCOA/ePRO Market Environment: Examines how respondents’ companies are utilizing
eCOA/ePRO systems, how these systems are impacting clinical trial activity, and how they
could see these systems improved moving forward.
6.	 eCOA/ePRO Provider Selection Criteria: Outlines the criteria by which sponsors and
CROs select service providers for eCOA/ePRO-related services as well as respondents’
preferences for specific eCOA/ePRO technologies.
7.	 eCOA/ePRO Service Provider Performance: Evaluates the performance of 22 different
eCOA/ePRO service providers across 21 different performance attributes.
8.	 Demographics: Provides the reader with an understanding of the demographics for the
166 respondents whose opinions are gathered and evaluated in this report.
•	 Project Managers
•	 Outsourcing
•	 Clinical Operations
•	 Data Management
•	 CROs
•	 Technology Service Providers
Major Sections:
Regions Analyzed: Valuable for:
56% North America
35% Europe
10% Asia, Latin America, Middle East/India
www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 3
act with confidence
Report Metrics
What you will learn in this report:
For Sponsors and CROs:
•	 651 EDC product experiences and 432 ePRO
product experiences with 22 EDC and 22
eCOA/ePRO products
•	 Past and future penetration of EDC
and ePRO technologies (by phase of
development)
•	 Which technology providers have the
best integration capabilities with other
technologies
For Technology Providers:
•	 Detailed performance profiles, product
satisfaction, and end-user preference for
44 major technology providers across core
performance attributes
•	 Current and future adoption estimates for
EDC and eCOA/ePRO technologies
How you can use this report:
For Sponsors and CROs:
•	 Select or uncover a new technology partner
that enhances your relationships with sites
by understanding the needs, wants, and
preferences of clinical sites
•	 Learn how sites, CROs, and sponsors would
recommend improving the trial process
•	 Benchmark your organization’s use of EDC
and eCOA/ePRO against broad industry
averages
For Technology Providers:
•	 Benchmark your performance against your
competition
•	 Anticipate how changes in trial volume and
adoption/penetration will affect your future
business opportunities
•	 Identify operational improvements and
product characteristics that impact trial
•	 Acceliant/Trianz
•	 BioClinica/Express EDC
•	 CiSIV
•	 Clinical Ink
•	 Clinipace (Tempo)
•	 Clinovo/ClinCapture
•	 Cmed (Timaeus)
•	 DataLabs
•	 DATATRAK
•	 DSG
•	 Forte Research Systems/Overture
EDC
•	 Medidata (Rave)
•	 MedNet Solutions
•	 Medrio
•	 Merge eClinical OS
•	 Nextrials (Prism)
•	 Octagon (Fuse)
•	 OmniComm (TrialMaster)
•	 OpenClinica
•	 Oracle/Phase Forward (InForm)
•	 Target Health
•	 Xclinical (Marvin)
•	 Almac
•	 AMC Health
•	 Biomedical Systems
(Michelangelo)
•	 Bracket Global/Arrowhead
•	 Clinipace (Tempo)
•	 ClinPhone IVR ePRO (by
PAREXEL)
•	 CRF Health (TrialMax)
•	 DATATRAK ONE UX Patient Data
Capture
•	 DSG (eDiaryLink)
•	 ePharmaSolutions
•	 ERT/invivodata (diarypro/ sitepro)
•	 Exco Intouch
•	 ICOPhone (by ICON Clinical)
•	 Inspire
•	 Medidata Patient Cloud
•	 mProve Health (formerly
Omniscience)
•	 OutcomeLogix (by Oracle)
•	 PatientsLikeMe
•	 PharmaNet/i3 IRT (by inVentiv
Health Clinical)
•	 PHT
•	 Symfo
•	 Y-Prime
eCOA/ePRO Products Included:
EDC Products Included:
www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 4
act with confidence
Table of Contents
For full table of contents and additional sample pages, download the full
preview from: www.isrreports.com/?p=5699
www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 5
act with confidence
act with confidence
Introduction
www.ISRreports.com ©2015 | EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 7
Introduction
Electronic data capture (EDC), electronic clinical outcome assessments (eCOA),
and electronic patient reported outcomes (ePRO) systems have become essential
and effective tools to appropriately capture, review, and even present the data
accumulated throughout the course of a clinical trial� While paper CRFs are still
preferred by some respondents, that figure is dwindling� EDC has become the
standard tool for its job in clinical trials across the board� Similarly, eCOA and ePRO
systems ensure that the data collected during a clinical trial are of the highest quality�
Ever more, sponsors and CROs alike are turning to these systems to ensure the highest
quality data and to save money by reducing trial delays associated with data capture
difficulties�
This report examines the industry perception of the EDC and eCOA/ePRO markets
based on the responses of over 150 industry professionals experienced with these
systems� ISR has asked respondents how their respective companies handle the
decisions associated with outsourcing these systems as well as how they would prefer
the outsourcing be handled� Additionally, ISR has benchmarked 22 EDC and 22 eCOA/
ePRO systems based on 651 EDC and 432 ePRO service provider encounters� Each
provider’s performance is benchmarked based on the performance of these providers
against expectations across 18-21 attributes� While the specifics of these ratings are
contained within this report, ISR wanted to include a comparison of a piece of this
year’s data to historical data captured in a previous version of this report� In 2013,
ISR found that 2 providers accounted for over 50% of the EDC service encounters of
respondents� Similarly, 4 companies accounted for over 50% of eCOA/ePRO service
encounters� Interestingly, as the market for these services grows, so too does the
space for additional successful providers of these services� In this year’s report, 5 EDC
providers and 7 ePRO providers make up over 50% of service encounters�
www.ISRreports.com	
  ©2015| EDC	
  and	
  eCOA/ePRO	
  Market	
  Dynamics	
  and	
  Service	
  Provider	
  Performance	
  (2015)	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  7	
  
Introduction
Electronic data capture (EDC), electronic clinical outcome assessments (eCOA), and
electronic patient reported outcomes (ePRO) systems have become essential and
effective tools to appropriately capture, review and even present the data accumulated
throughout the course of a clinical trial. While paper CRFs are still preferred by some
respondents, that figure is dwindling. EDC has become the standard tool for its job in
clinical trials across the board. Similarly, eCOA and ePRO systems ensure that the data
collected during a clinical trial are of the highest quality. Ever more, sponsors and
CROs alike are turning to these systems to ensure the highest quality data, and to save
money by reducing trial delays associated to difficulties related with data capture.
This report examines the industry perception of the EDC and eCOA/ePRO markets
based on the responses of over 150 industry professionals experienced with these
systems. ISR has asked respondents how their respective companies handle the
decisions associated with outsourcing these systems as well as how they would prefer
the outsourcing be handled. Additionally, ISR has benchmarked 22 EDC and 22
eCOA/ePRO systems based on 651 EDC and 432 ePRO service provider encounters.
Each provider’s performance is benchmarked based on the performance of these
providers against expectations across 18/21 attributes. While the specifics of these
ratings are contained within this report, ISR wanted to include a comparison of a piece
of this year’s data to historical data captured in a previous version of this report. In
2013, ISR found that 2 providers accounted for over 50% of the EDC service
encounters of respondents. Similarly, 4 companies accounted for over 50% of
eCOA/ePRO service encounters. Interestingly, as the market for these services grows,
so too does the space for additional successful providers of these services. In this
year’s report, 5 EDC providers and 7 ePRO providers make up over 50% of service
encounters.
0%
25%
50%
75%
100%
1	
   2	
   3	
   4	
   5	
   6	
   7	
   8	
   9	
   10	
  
%ofServiceEncounters
Provider Concentration
EDC ePRO
Number of providers
Provider Concentration (2015)
Sample Page
www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 6
act with confidence
act with confidence
Executive Summary
www.ISRreports.com ©2015 | EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 20
Service Provider Performance by Category
ISR asked respondents to rate each eCOA/ePRO provider they have recently used
across 21 different dimensions of performance� ISR’s methodology for doing so
asks each user to rate the service’s performance vs� the user’s expectations for each
dimension� Scores are assigned to ratings as follows:
• Greatly exceeded my expectations; +3
• Somewhat exceeded my expectations: +1
• Met my expectations: 0
• Somewhat fell short of my expectations: -1
• Greatly fell short of my expectations: -3
ISR then organized these attributes into categories and produced an average score
for each category� The chart below shows the first, second, and third highest rated
companies by category as well as those companies that were close contenders�
ERT/invivodata (diarypro/sitepro) and ClinPhone IVR ePRO (by PAREXEL) appear in
the top 4 in 5 of the 6 performance categories� Outcome Logix (by Oracle) despite
not being heavily used by respondents ranked in the top 2 in 4 of six categories� This
suggests that in addition to OutcomeLogix exceeding performance expectations by
users, they may have opportunity for growth� ERT/invivodata and ClinPhone both
have high performance scores but are also used more often than OutcomeLogix� For
sponsors, it may be worth exploring the services offered by OutcomeLogix, particularly
since one of the categories in which they lead is Reasonableness of Cost.
Attributes
Rated Highest Second Highest Third Highest Close Contenders
Overall
satisfaction
ERT/invivodata
(diarypro/sitepro)
Medidata Patient
Cloud
CRF Health (TrialMax)
Inspire
ClinPhone IVR ePRO
(PAREXEL)
Almac
Reasonableness
of Cost
OutcomeLogix
(Oracle)
AMC Health
ClinPhone IVR ePRO
(PAREXEL)
Biomedical Systems
(Michelangelo)
Usability
ERT/invivodata
(diarypro/sitepro)
OutcomeLogix
(Oracle)
Almac
ClinPhone IVR ePRO
(PAREXEL)
System/Device
Integration
OutcomeLogix
(Oracle)
ClinPhone IVR
ePRO (PAREXEL)
ERT/invivodata
(diarypro/sitepro)
AMC Health
CRF Health (TrialMax)
System Flexibility
and Support
ERT/invivodata
(diarypro/sitepro)
ClinPhone IVR
ePRO (PAREXEL)
Almac PHT
Validation
and Patient
Compliance
ERT/invivodata
(diarypro/sitepro)
OutcomeLogix
(Oracle)
Biomedical Systems
(Michelangelo)
ClinPhone IVR ePRO
(PAREXEL)
Sample Page
Attributes
Rated Highest Second Highest Third Highest Close Contenders
Overall
satisfaction
Company A Company C
Company F
Company J
Company E
Company G
Reasonableness
of Cost
Company B Company D Company E Company H
Usability Company A Company B
Company G
Company E
System/Device
Integration
Company B Company E Company A
Company G
Company F
System Flexibility
and Support
Company A Company E
Company G
Company I
Validation
and Patient
Compliance
Company A Company B Company H Company E
Service Provider Performance by Category
ISR asked respondents to rate each eCOA/ePRO provider they have recently used across 21
different dimensions of performance. ISR’s methodology for doing so asks each user to rate the
service’s performance vs. the user’s expectations for each dimension. Scores are assigned to
ratings as follows:
•	 Greatly exceeded my expectations: +3
•	 Somewhat exceeded my expectations: +1
•	 Met my expectations: 0
•	 Somewhat fell short of my expectations: -1
•	 Greatly fell short of my expectations: -3
ISR then organized these attributes into categories and produced an average score for each
category. The chart below shows the first, second, and third highest rated companies
by category as well as those companies that were close contenders.
Company A and Company E appear in the top 4 in 5 of the 6 performance
categories. Company B despite not being heavily used by respondents ranked
in the top 2 in 4 of six categories. This suggests that in addition to Company B
exceeding performance expectations by users, they may have opportunity for growth.
Company A and Company E both have high performance scores but are also used
more often than Company B. For sponsors, it may be worth exploring the services
offered by Company B, particularly since one of the categories in which they lead is
Reasonableness of Cost.
www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 7
act with confidence
Sample Page
act with confidence
EDC Provider Selection Criteria
www.ISRreports.com ©2015 | EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 42
Contract Directly vs� Going
through CRO for EDC
Components
Roughly half the time, sponsors contract directly with an EDC provider as opposed to
going through the CRO� Moving forward, this figure is expected to increase by roughly
10 percentage points� Similarly, moving forward, CROs expect a decline in how often
the sponsor almost always contracts through our organization (being the CRO)�
Currently 52% of respondents from CROs say this, but in three years’ time, only 39% of
CRO respondents expect this to be the case�
“Currently, when your organization is using a CRO for a clinical study that has an EDC
component, what percent of the time do you contract directly with an EDC provider
as opposed to going through the CRO?” (Base=50; sponsors only)
“Thinking three years into the future, when your organization is using a CRO for a
clinical study that has an EDC component, what percent of the time will you contract
directly with an EDC provider as opposed to going through the CRO?” (Base=48;
sponsors only)
43%
52%
www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 8
act with confidence
Sample Page
For full table of contents and additional sample pages, download the full
preview from: www.isrreports.com/?p=5699
www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 9
act with confidence
Ordering Information
Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services indus-
tries.  With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise. 
 
For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at
www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports.
About Industry Standard Research
Save on this,
or any ISR
report, by
registering a
free account
Register now
•	 Receive a $250 instant credit towards any ISR report
•	 Earn 10% credit towards all future purchases
•	 Receive advanced notifications on ISR’s latest reports and free resources
For pricing and ordering information visit: www.isrreports.com/?p=5699
www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 10
act with confidence
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10
act with confidence
www.ISRreports.com ©2015 | Preview of: Epithelial Ovarian Cancer: Disease and Pipeline Analysis 10
act with confidence
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10
act with confidence
www.ISRreports.com ©2014 | Preview of: Benchmarking European Investigator Payments 10
act with confidence
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10
act with confidence
The ISR Difference
Custom-quality syndicated market research
www.ISRreports.com
ISR's Reports
The Common
Syndicated Reportvs.
How confident are you?
vs.
DataCollection
ISR's proprietary data collection
tools and channels support fast,
high quality data collection
Struggle to recruit the right
targets and enough of them
vs.
SampleSizes
Robust sample sizes that
instill confidence
Often insufficient industry
representation that leaves you
defending results
vs.vs.
Research methods
Mostly primary
research;
always appropriate
for the topic
One size fits all;
usually publically
available data
vs.vs.
Respondents
Sophisticated screening
ensures genuine
decision-makers
Undisclosed
methodologies and
respondent demographics
vs.vs.
Analysts
Decades of experience
means more insights that are
immediately usable
Junior analysts capable of
reporting numbers

More Related Content

What's hot

Clinical data management
Clinical data managementClinical data management
Clinical data management
Upendra Agarwal
 
Medical Devices, Interoperability & eHealth Standardization
Medical Devices, Interoperability & eHealth Standardization Medical Devices, Interoperability & eHealth Standardization
Medical Devices, Interoperability & eHealth Standardization
Prof. Rajendra Pratap Gupta
 
Ich efficacy3 by Ramkrisna Bhunjawa
Ich efficacy3 by Ramkrisna Bhunjawa Ich efficacy3 by Ramkrisna Bhunjawa
Ich efficacy3 by Ramkrisna Bhunjawa
bhunjawa
 
Pharmaceutical Regulations in GCC countries
Pharmaceutical Regulations in GCC countriesPharmaceutical Regulations in GCC countries
Pharmaceutical Regulations in GCC countries
Iman Ajami
 
Iso13485 ppt
Iso13485 pptIso13485 ppt
Iso13485 ppt
Rajashekhara Gowda
 
Business Models For Biotech Firms
Business Models For Biotech FirmsBusiness Models For Biotech Firms
Business Models For Biotech Firms
Alberto Onetti
 
ICH - quality guidelines
ICH - quality guidelinesICH - quality guidelines
ICH - quality guidelines
ManishShankarpure
 
Accelerating Patient Care with Real World Evidence
Accelerating Patient Care with Real World EvidenceAccelerating Patient Care with Real World Evidence
Accelerating Patient Care with Real World Evidence
CitiusTech
 
Regulatory Intelligence
Regulatory IntelligenceRegulatory Intelligence
Regulatory Intelligence
Shruti Kargutkar
 
Key Concepts of Clinical Research & Clinical Trial
Key Concepts of Clinical Research & Clinical Trial Key Concepts of Clinical Research & Clinical Trial
Key Concepts of Clinical Research & Clinical Trial
SWAROOP KUMAR K
 
ANDA Submission.pptx
ANDA Submission.pptxANDA Submission.pptx
ANDA Submission.pptx
KuntalKapure
 
Introduction to clinical sas programming
Introduction to clinical sas programmingIntroduction to clinical sas programming
Introduction to clinical sas programming
ray4hz
 
Usfda
Usfda Usfda
Usfda
Hemang Patel
 
Introduction to clinical sas
Introduction to clinical sasIntroduction to clinical sas
Introduction to clinical sas
Vijayaraghava Karpurapu
 
Veeva Systems Webinar: Driving Continuous Quality Improvements
Veeva Systems Webinar: Driving Continuous Quality ImprovementsVeeva Systems Webinar: Driving Continuous Quality Improvements
Veeva Systems Webinar: Driving Continuous Quality Improvements
Veeva Systems
 
Clinical Development of Biosimilars
Clinical Development of Biosimilars Clinical Development of Biosimilars
Clinical Development of Biosimilars
Bhaswat Chakraborty
 
Presentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & APresentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & A
TGA Australia
 
medical device regulatory approval in USA
medical device regulatory approval in USAmedical device regulatory approval in USA
medical device regulatory approval in USA
Suraj Pamadi
 
5 Different Types of Medical Writing
5 Different Types of Medical Writing5 Different Types of Medical Writing
5 Different Types of Medical Writing
Brandon May
 
Quality management system
Quality management systemQuality management system
Quality management systempareshpanshikar
 

What's hot (20)

Clinical data management
Clinical data managementClinical data management
Clinical data management
 
Medical Devices, Interoperability & eHealth Standardization
Medical Devices, Interoperability & eHealth Standardization Medical Devices, Interoperability & eHealth Standardization
Medical Devices, Interoperability & eHealth Standardization
 
Ich efficacy3 by Ramkrisna Bhunjawa
Ich efficacy3 by Ramkrisna Bhunjawa Ich efficacy3 by Ramkrisna Bhunjawa
Ich efficacy3 by Ramkrisna Bhunjawa
 
Pharmaceutical Regulations in GCC countries
Pharmaceutical Regulations in GCC countriesPharmaceutical Regulations in GCC countries
Pharmaceutical Regulations in GCC countries
 
Iso13485 ppt
Iso13485 pptIso13485 ppt
Iso13485 ppt
 
Business Models For Biotech Firms
Business Models For Biotech FirmsBusiness Models For Biotech Firms
Business Models For Biotech Firms
 
ICH - quality guidelines
ICH - quality guidelinesICH - quality guidelines
ICH - quality guidelines
 
Accelerating Patient Care with Real World Evidence
Accelerating Patient Care with Real World EvidenceAccelerating Patient Care with Real World Evidence
Accelerating Patient Care with Real World Evidence
 
Regulatory Intelligence
Regulatory IntelligenceRegulatory Intelligence
Regulatory Intelligence
 
Key Concepts of Clinical Research & Clinical Trial
Key Concepts of Clinical Research & Clinical Trial Key Concepts of Clinical Research & Clinical Trial
Key Concepts of Clinical Research & Clinical Trial
 
ANDA Submission.pptx
ANDA Submission.pptxANDA Submission.pptx
ANDA Submission.pptx
 
Introduction to clinical sas programming
Introduction to clinical sas programmingIntroduction to clinical sas programming
Introduction to clinical sas programming
 
Usfda
Usfda Usfda
Usfda
 
Introduction to clinical sas
Introduction to clinical sasIntroduction to clinical sas
Introduction to clinical sas
 
Veeva Systems Webinar: Driving Continuous Quality Improvements
Veeva Systems Webinar: Driving Continuous Quality ImprovementsVeeva Systems Webinar: Driving Continuous Quality Improvements
Veeva Systems Webinar: Driving Continuous Quality Improvements
 
Clinical Development of Biosimilars
Clinical Development of Biosimilars Clinical Development of Biosimilars
Clinical Development of Biosimilars
 
Presentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & APresentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & A
 
medical device regulatory approval in USA
medical device regulatory approval in USAmedical device regulatory approval in USA
medical device regulatory approval in USA
 
5 Different Types of Medical Writing
5 Different Types of Medical Writing5 Different Types of Medical Writing
5 Different Types of Medical Writing
 
Quality management system
Quality management systemQuality management system
Quality management system
 

Similar to EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)

Infographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and TechnologyInfographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and Technology
Industry Standard Research
 
EMRs and Clinical Research: Current and Potential Impact
EMRs and Clinical Research: Current and Potential ImpactEMRs and Clinical Research: Current and Potential Impact
EMRs and Clinical Research: Current and Potential Impact
Industry Standard Research
 
Unified Clinical Operations - Ennov Presentation
Unified Clinical Operations - Ennov PresentationUnified Clinical Operations - Ennov Presentation
Unified Clinical Operations - Ennov Presentation
Ennov
 
IT Outsourcing (ITO) in the Life Sciences Industry - Service Provider Landscape
IT Outsourcing (ITO) in the Life Sciences Industry - Service Provider LandscapeIT Outsourcing (ITO) in the Life Sciences Industry - Service Provider Landscape
IT Outsourcing (ITO) in the Life Sciences Industry - Service Provider Landscape
Everest Group
 
IT Application Outsourcing (AO) in the Healthcare Provider Industry - Service...
IT Application Outsourcing (AO) in the Healthcare Provider Industry - Service...IT Application Outsourcing (AO) in the Healthcare Provider Industry - Service...
IT Application Outsourcing (AO) in the Healthcare Provider Industry - Service...
Everest Group
 
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...
IMARC Group
 
Ovum Decision Matrix
Ovum Decision MatrixOvum Decision Matrix
Ovum Decision Matrix
Francisco González Jiménez
 
Benefits of Using an EDC System
Benefits of Using an EDC SystemBenefits of Using an EDC System
Benefits of Using an EDC System
TrialJoin
 
Medisolv Quality Reporting Software
Medisolv Quality Reporting SoftwareMedisolv Quality Reporting Software
Medisolv Quality Reporting Software
Medisolv, Inc.
 
EHR recommendations_UNCG_Deligianis_Taneja_Kutas
EHR recommendations_UNCG_Deligianis_Taneja_KutasEHR recommendations_UNCG_Deligianis_Taneja_Kutas
EHR recommendations_UNCG_Deligianis_Taneja_KutasDavid Kutas
 
Open Source Services Market by Product Type, Distribution Channel, End User 2...
Open Source Services Market by Product Type, Distribution Channel, End User 2...Open Source Services Market by Product Type, Distribution Channel, End User 2...
Open Source Services Market by Product Type, Distribution Channel, End User 2...
IMARC Group
 
Detailed Project Report on Cholesterol Testing System Manufacturing Unit Setup
Detailed Project Report on Cholesterol Testing System Manufacturing Unit SetupDetailed Project Report on Cholesterol Testing System Manufacturing Unit Setup
Detailed Project Report on Cholesterol Testing System Manufacturing Unit Setup
IMARC Group
 
South Korea Green Data Center Market by Product Type, Distribution Channel, E...
South Korea Green Data Center Market by Product Type, Distribution Channel, E...South Korea Green Data Center Market by Product Type, Distribution Channel, E...
South Korea Green Data Center Market by Product Type, Distribution Channel, E...
IMARC Group
 
Business Process Management and its evolution An ACOG example - steve hasle...
Business Process Management and its evolution   An ACOG example - steve hasle...Business Process Management and its evolution   An ACOG example - steve hasle...
Business Process Management and its evolution An ACOG example - steve hasle...
Denis Gagné
 
India DC Power Systems Market Forecast & Opportunities, 2014 – 2024| TechSci ...
India DC Power Systems Market Forecast & Opportunities, 2014 – 2024| TechSci ...India DC Power Systems Market Forecast & Opportunities, 2014 – 2024| TechSci ...
India DC Power Systems Market Forecast & Opportunities, 2014 – 2024| TechSci ...
TechSci Research
 
Oracle communications data model product overview
Oracle communications data model   product overviewOracle communications data model   product overview
Oracle communications data model product overview
GreenHamster
 
CRASH Report 2014
CRASH Report 2014CRASH Report 2014
CRASH Report 2014
CAST
 
Electric Bus Manufacturing Plant Project .pptx
Electric Bus Manufacturing Plant Project .pptxElectric Bus Manufacturing Plant Project .pptx
Electric Bus Manufacturing Plant Project .pptx
rudrap2099
 
5 Ways to Collect ePRO
5 Ways to Collect ePRO5 Ways to Collect ePRO
5 Ways to Collect ePRO
Chris Teel Hall
 

Similar to EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) (20)

Infographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and TechnologyInfographic: eClinical Trends, Tips, and Technology
Infographic: eClinical Trends, Tips, and Technology
 
EMRs and Clinical Research: Current and Potential Impact
EMRs and Clinical Research: Current and Potential ImpactEMRs and Clinical Research: Current and Potential Impact
EMRs and Clinical Research: Current and Potential Impact
 
Unified Clinical Operations - Ennov Presentation
Unified Clinical Operations - Ennov PresentationUnified Clinical Operations - Ennov Presentation
Unified Clinical Operations - Ennov Presentation
 
IT Outsourcing (ITO) in the Life Sciences Industry - Service Provider Landscape
IT Outsourcing (ITO) in the Life Sciences Industry - Service Provider LandscapeIT Outsourcing (ITO) in the Life Sciences Industry - Service Provider Landscape
IT Outsourcing (ITO) in the Life Sciences Industry - Service Provider Landscape
 
IT Application Outsourcing (AO) in the Healthcare Provider Industry - Service...
IT Application Outsourcing (AO) in the Healthcare Provider Industry - Service...IT Application Outsourcing (AO) in the Healthcare Provider Industry - Service...
IT Application Outsourcing (AO) in the Healthcare Provider Industry - Service...
 
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...
 
Ovum Decision Matrix
Ovum Decision MatrixOvum Decision Matrix
Ovum Decision Matrix
 
Benefits of Using an EDC System
Benefits of Using an EDC SystemBenefits of Using an EDC System
Benefits of Using an EDC System
 
Medisolv Quality Reporting Software
Medisolv Quality Reporting SoftwareMedisolv Quality Reporting Software
Medisolv Quality Reporting Software
 
EHR recommendations_UNCG_Deligianis_Taneja_Kutas
EHR recommendations_UNCG_Deligianis_Taneja_KutasEHR recommendations_UNCG_Deligianis_Taneja_Kutas
EHR recommendations_UNCG_Deligianis_Taneja_Kutas
 
Open Source Services Market by Product Type, Distribution Channel, End User 2...
Open Source Services Market by Product Type, Distribution Channel, End User 2...Open Source Services Market by Product Type, Distribution Channel, End User 2...
Open Source Services Market by Product Type, Distribution Channel, End User 2...
 
Detailed Project Report on Cholesterol Testing System Manufacturing Unit Setup
Detailed Project Report on Cholesterol Testing System Manufacturing Unit SetupDetailed Project Report on Cholesterol Testing System Manufacturing Unit Setup
Detailed Project Report on Cholesterol Testing System Manufacturing Unit Setup
 
South Korea Green Data Center Market by Product Type, Distribution Channel, E...
South Korea Green Data Center Market by Product Type, Distribution Channel, E...South Korea Green Data Center Market by Product Type, Distribution Channel, E...
South Korea Green Data Center Market by Product Type, Distribution Channel, E...
 
Business Process Management and its evolution An ACOG example - steve hasle...
Business Process Management and its evolution   An ACOG example - steve hasle...Business Process Management and its evolution   An ACOG example - steve hasle...
Business Process Management and its evolution An ACOG example - steve hasle...
 
India DC Power Systems Market Forecast & Opportunities, 2014 – 2024| TechSci ...
India DC Power Systems Market Forecast & Opportunities, 2014 – 2024| TechSci ...India DC Power Systems Market Forecast & Opportunities, 2014 – 2024| TechSci ...
India DC Power Systems Market Forecast & Opportunities, 2014 – 2024| TechSci ...
 
Oracle communications data model product overview
Oracle communications data model   product overviewOracle communications data model   product overview
Oracle communications data model product overview
 
EMR in Europe
EMR in EuropeEMR in Europe
EMR in Europe
 
CRASH Report 2014
CRASH Report 2014CRASH Report 2014
CRASH Report 2014
 
Electric Bus Manufacturing Plant Project .pptx
Electric Bus Manufacturing Plant Project .pptxElectric Bus Manufacturing Plant Project .pptx
Electric Bus Manufacturing Plant Project .pptx
 
5 Ways to Collect ePRO
5 Ways to Collect ePRO5 Ways to Collect ePRO
5 Ways to Collect ePRO
 

More from Industry Standard Research

Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Industry Standard Research
 
Electronic Media Use in Academic Medical Center Patient Recruitment
Electronic Media Use in Academic Medical Center Patient RecruitmentElectronic Media Use in Academic Medical Center Patient Recruitment
Electronic Media Use in Academic Medical Center Patient Recruitment
Industry Standard Research
 
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensPersonalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Industry Standard Research
 
Regulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresRegulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and Structures
Industry Standard Research
 
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
Industry Standard Research
 
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Industry Standard Research
 
Market Access: department models and structures
Market Access: department  models and structuresMarket Access: department  models and structures
Market Access: department models and structures
Industry Standard Research
 
Infographic: The World of Drug Development Trends
Infographic: The World of Drug Development TrendsInfographic: The World of Drug Development Trends
Infographic: The World of Drug Development Trends
Industry Standard Research
 
Orphan Drug 101
Orphan Drug 101Orphan Drug 101
Infographic: Ovarian Cancer Profile
Infographic: Ovarian Cancer ProfileInfographic: Ovarian Cancer Profile
Infographic: Ovarian Cancer Profile
Industry Standard Research
 
Infographic: CRO Capital Market
Infographic: CRO Capital MarketInfographic: CRO Capital Market
Infographic: CRO Capital Market
Industry Standard Research
 
2014 Clinical Development Year in Review
2014 Clinical Development Year in Review2014 Clinical Development Year in Review
2014 Clinical Development Year in Review
Industry Standard Research
 
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
Infographic: Thyroid Cancer:  Disease and Pipeline AnalysisInfographic: Thyroid Cancer:  Disease and Pipeline Analysis
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
Industry Standard Research
 
Benchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs FunctionsBenchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs Functions
Industry Standard Research
 
Bladder Cancer: profile and drug development
Bladder Cancer: profile and drug developmentBladder Cancer: profile and drug development
Bladder Cancer: profile and drug development
Industry Standard Research
 
Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...
Industry Standard Research
 
[Infographic] Lung Cancer
[Infographic] Lung Cancer[Infographic] Lung Cancer
[Infographic] Lung Cancer
Industry Standard Research
 
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug DevelopmentBrain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Industry Standard Research
 
Clinical Development Year in Review (2013)
Clinical Development Year in Review (2013)  Clinical Development Year in Review (2013)
Clinical Development Year in Review (2013)
Industry Standard Research
 
What does the future hold for Detailing and drug reps?
What does the future hold for Detailing and drug reps?What does the future hold for Detailing and drug reps?
What does the future hold for Detailing and drug reps?
Industry Standard Research
 

More from Industry Standard Research (20)

Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
Bioanalytical Labs Market Dynamics and Service Provider Performance (3rd Edit...
 
Electronic Media Use in Academic Medical Center Patient Recruitment
Electronic Media Use in Academic Medical Center Patient RecruitmentElectronic Media Use in Academic Medical Center Patient Recruitment
Electronic Media Use in Academic Medical Center Patient Recruitment
 
Personalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment RegimensPersonalized Medicine's Effect on Oncologists' Treatment Regimens
Personalized Medicine's Effect on Oncologists' Treatment Regimens
 
Regulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresRegulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and Structures
 
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
CRO Quality Benchmarking – Phase IV Service Providers (8th EDITION)
 
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)Fill Finish Contract Manufacturer Quality Benchmarking (2016)
Fill Finish Contract Manufacturer Quality Benchmarking (2016)
 
Market Access: department models and structures
Market Access: department  models and structuresMarket Access: department  models and structures
Market Access: department models and structures
 
Infographic: The World of Drug Development Trends
Infographic: The World of Drug Development TrendsInfographic: The World of Drug Development Trends
Infographic: The World of Drug Development Trends
 
Orphan Drug 101
Orphan Drug 101Orphan Drug 101
Orphan Drug 101
 
Infographic: Ovarian Cancer Profile
Infographic: Ovarian Cancer ProfileInfographic: Ovarian Cancer Profile
Infographic: Ovarian Cancer Profile
 
Infographic: CRO Capital Market
Infographic: CRO Capital MarketInfographic: CRO Capital Market
Infographic: CRO Capital Market
 
2014 Clinical Development Year in Review
2014 Clinical Development Year in Review2014 Clinical Development Year in Review
2014 Clinical Development Year in Review
 
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
Infographic: Thyroid Cancer:  Disease and Pipeline AnalysisInfographic: Thyroid Cancer:  Disease and Pipeline Analysis
Infographic: Thyroid Cancer: Disease and Pipeline Analysis
 
Benchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs FunctionsBenchmarking the Pharma Industry’s Medical Affairs Functions
Benchmarking the Pharma Industry’s Medical Affairs Functions
 
Bladder Cancer: profile and drug development
Bladder Cancer: profile and drug developmentBladder Cancer: profile and drug development
Bladder Cancer: profile and drug development
 
Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...Clinical development activity in perspective: A head-to-head comparison of ...
Clinical development activity in perspective: A head-to-head comparison of ...
 
[Infographic] Lung Cancer
[Infographic] Lung Cancer[Infographic] Lung Cancer
[Infographic] Lung Cancer
 
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug DevelopmentBrain Cancer (Glioblastoma Multiforme): Profile & Drug Development
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
 
Clinical Development Year in Review (2013)
Clinical Development Year in Review (2013)  Clinical Development Year in Review (2013)
Clinical Development Year in Review (2013)
 
What does the future hold for Detailing and drug reps?
What does the future hold for Detailing and drug reps?What does the future hold for Detailing and drug reps?
What does the future hold for Detailing and drug reps?
 

Recently uploaded

Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
SwastikAyurveda
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
SwisschemDerma
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 

Recently uploaded (20)

Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 

EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015)

  • 1. 20152015 EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) Info@ISRreports.com ©2015 Industry Standard Research www.ISRreports.com PREVIEW
  • 2. www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 2 act with confidence Report Overview This report examines the industry perception of the EDC and eCOA/ePRO markets based on the responses of over 150 industry professionals experienced with these systems. ISR has asked respondents how their respective companies handle the decisions associated with outsourcing these systems as well as how they would prefer the outsourcing be handled. Additionally, ISR has benchmarked 22 EDC and 22 eCOA/ePRO systems based on 651 EDC and 432 ePRO service provider encounters. Each provider’s performance is evaluated and benchmarked based on the performance of these providers against expectations across 18-21 attributes. 166Respondents 136Pages 121Charts and Graphs Q2, 2015 Publication Date 1. Executive Summary: In this section, ISR summarizes the key findings found throughout the report. The majority of these data are examined in more detail in the subsequent sections. 2. EDC Market Environment: Examines how respondents’ companies are utilizing EDC systems, how these systems are impacting clinical trial activity, and how they could see these systems improved moving forward. 3. EDC Provider Selection Criteria: Outlines the criteria by which sponsors and CROs select service providers for EDC-related services as well as respondents’ preferences for specific EDC platforms. 4. EDC Service Provider Performance: Evaluates the performance of 22 different EDC service providers across 18 different performance attributes. 5. eCOA/ePRO Market Environment: Examines how respondents’ companies are utilizing eCOA/ePRO systems, how these systems are impacting clinical trial activity, and how they could see these systems improved moving forward. 6. eCOA/ePRO Provider Selection Criteria: Outlines the criteria by which sponsors and CROs select service providers for eCOA/ePRO-related services as well as respondents’ preferences for specific eCOA/ePRO technologies. 7. eCOA/ePRO Service Provider Performance: Evaluates the performance of 22 different eCOA/ePRO service providers across 21 different performance attributes. 8. Demographics: Provides the reader with an understanding of the demographics for the 166 respondents whose opinions are gathered and evaluated in this report. • Project Managers • Outsourcing • Clinical Operations • Data Management • CROs • Technology Service Providers Major Sections: Regions Analyzed: Valuable for: 56% North America 35% Europe 10% Asia, Latin America, Middle East/India
  • 3. www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 3 act with confidence Report Metrics What you will learn in this report: For Sponsors and CROs: • 651 EDC product experiences and 432 ePRO product experiences with 22 EDC and 22 eCOA/ePRO products • Past and future penetration of EDC and ePRO technologies (by phase of development) • Which technology providers have the best integration capabilities with other technologies For Technology Providers: • Detailed performance profiles, product satisfaction, and end-user preference for 44 major technology providers across core performance attributes • Current and future adoption estimates for EDC and eCOA/ePRO technologies How you can use this report: For Sponsors and CROs: • Select or uncover a new technology partner that enhances your relationships with sites by understanding the needs, wants, and preferences of clinical sites • Learn how sites, CROs, and sponsors would recommend improving the trial process • Benchmark your organization’s use of EDC and eCOA/ePRO against broad industry averages For Technology Providers: • Benchmark your performance against your competition • Anticipate how changes in trial volume and adoption/penetration will affect your future business opportunities • Identify operational improvements and product characteristics that impact trial • Acceliant/Trianz • BioClinica/Express EDC • CiSIV • Clinical Ink • Clinipace (Tempo) • Clinovo/ClinCapture • Cmed (Timaeus) • DataLabs • DATATRAK • DSG • Forte Research Systems/Overture EDC • Medidata (Rave) • MedNet Solutions • Medrio • Merge eClinical OS • Nextrials (Prism) • Octagon (Fuse) • OmniComm (TrialMaster) • OpenClinica • Oracle/Phase Forward (InForm) • Target Health • Xclinical (Marvin) • Almac • AMC Health • Biomedical Systems (Michelangelo) • Bracket Global/Arrowhead • Clinipace (Tempo) • ClinPhone IVR ePRO (by PAREXEL) • CRF Health (TrialMax) • DATATRAK ONE UX Patient Data Capture • DSG (eDiaryLink) • ePharmaSolutions • ERT/invivodata (diarypro/ sitepro) • Exco Intouch • ICOPhone (by ICON Clinical) • Inspire • Medidata Patient Cloud • mProve Health (formerly Omniscience) • OutcomeLogix (by Oracle) • PatientsLikeMe • PharmaNet/i3 IRT (by inVentiv Health Clinical) • PHT • Symfo • Y-Prime eCOA/ePRO Products Included: EDC Products Included:
  • 4. www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 4 act with confidence Table of Contents For full table of contents and additional sample pages, download the full preview from: www.isrreports.com/?p=5699
  • 5. www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 5 act with confidence act with confidence Introduction www.ISRreports.com ©2015 | EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 7 Introduction Electronic data capture (EDC), electronic clinical outcome assessments (eCOA), and electronic patient reported outcomes (ePRO) systems have become essential and effective tools to appropriately capture, review, and even present the data accumulated throughout the course of a clinical trial� While paper CRFs are still preferred by some respondents, that figure is dwindling� EDC has become the standard tool for its job in clinical trials across the board� Similarly, eCOA and ePRO systems ensure that the data collected during a clinical trial are of the highest quality� Ever more, sponsors and CROs alike are turning to these systems to ensure the highest quality data and to save money by reducing trial delays associated with data capture difficulties� This report examines the industry perception of the EDC and eCOA/ePRO markets based on the responses of over 150 industry professionals experienced with these systems� ISR has asked respondents how their respective companies handle the decisions associated with outsourcing these systems as well as how they would prefer the outsourcing be handled� Additionally, ISR has benchmarked 22 EDC and 22 eCOA/ ePRO systems based on 651 EDC and 432 ePRO service provider encounters� Each provider’s performance is benchmarked based on the performance of these providers against expectations across 18-21 attributes� While the specifics of these ratings are contained within this report, ISR wanted to include a comparison of a piece of this year’s data to historical data captured in a previous version of this report� In 2013, ISR found that 2 providers accounted for over 50% of the EDC service encounters of respondents� Similarly, 4 companies accounted for over 50% of eCOA/ePRO service encounters� Interestingly, as the market for these services grows, so too does the space for additional successful providers of these services� In this year’s report, 5 EDC providers and 7 ePRO providers make up over 50% of service encounters� www.ISRreports.com  ©2015| EDC  and  eCOA/ePRO  Market  Dynamics  and  Service  Provider  Performance  (2015)                    7   Introduction Electronic data capture (EDC), electronic clinical outcome assessments (eCOA), and electronic patient reported outcomes (ePRO) systems have become essential and effective tools to appropriately capture, review and even present the data accumulated throughout the course of a clinical trial. While paper CRFs are still preferred by some respondents, that figure is dwindling. EDC has become the standard tool for its job in clinical trials across the board. Similarly, eCOA and ePRO systems ensure that the data collected during a clinical trial are of the highest quality. Ever more, sponsors and CROs alike are turning to these systems to ensure the highest quality data, and to save money by reducing trial delays associated to difficulties related with data capture. This report examines the industry perception of the EDC and eCOA/ePRO markets based on the responses of over 150 industry professionals experienced with these systems. ISR has asked respondents how their respective companies handle the decisions associated with outsourcing these systems as well as how they would prefer the outsourcing be handled. Additionally, ISR has benchmarked 22 EDC and 22 eCOA/ePRO systems based on 651 EDC and 432 ePRO service provider encounters. Each provider’s performance is benchmarked based on the performance of these providers against expectations across 18/21 attributes. While the specifics of these ratings are contained within this report, ISR wanted to include a comparison of a piece of this year’s data to historical data captured in a previous version of this report. In 2013, ISR found that 2 providers accounted for over 50% of the EDC service encounters of respondents. Similarly, 4 companies accounted for over 50% of eCOA/ePRO service encounters. Interestingly, as the market for these services grows, so too does the space for additional successful providers of these services. In this year’s report, 5 EDC providers and 7 ePRO providers make up over 50% of service encounters. 0% 25% 50% 75% 100% 1   2   3   4   5   6   7   8   9   10   %ofServiceEncounters Provider Concentration EDC ePRO Number of providers Provider Concentration (2015) Sample Page
  • 6. www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 6 act with confidence act with confidence Executive Summary www.ISRreports.com ©2015 | EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 20 Service Provider Performance by Category ISR asked respondents to rate each eCOA/ePRO provider they have recently used across 21 different dimensions of performance� ISR’s methodology for doing so asks each user to rate the service’s performance vs� the user’s expectations for each dimension� Scores are assigned to ratings as follows: • Greatly exceeded my expectations; +3 • Somewhat exceeded my expectations: +1 • Met my expectations: 0 • Somewhat fell short of my expectations: -1 • Greatly fell short of my expectations: -3 ISR then organized these attributes into categories and produced an average score for each category� The chart below shows the first, second, and third highest rated companies by category as well as those companies that were close contenders� ERT/invivodata (diarypro/sitepro) and ClinPhone IVR ePRO (by PAREXEL) appear in the top 4 in 5 of the 6 performance categories� Outcome Logix (by Oracle) despite not being heavily used by respondents ranked in the top 2 in 4 of six categories� This suggests that in addition to OutcomeLogix exceeding performance expectations by users, they may have opportunity for growth� ERT/invivodata and ClinPhone both have high performance scores but are also used more often than OutcomeLogix� For sponsors, it may be worth exploring the services offered by OutcomeLogix, particularly since one of the categories in which they lead is Reasonableness of Cost. Attributes Rated Highest Second Highest Third Highest Close Contenders Overall satisfaction ERT/invivodata (diarypro/sitepro) Medidata Patient Cloud CRF Health (TrialMax) Inspire ClinPhone IVR ePRO (PAREXEL) Almac Reasonableness of Cost OutcomeLogix (Oracle) AMC Health ClinPhone IVR ePRO (PAREXEL) Biomedical Systems (Michelangelo) Usability ERT/invivodata (diarypro/sitepro) OutcomeLogix (Oracle) Almac ClinPhone IVR ePRO (PAREXEL) System/Device Integration OutcomeLogix (Oracle) ClinPhone IVR ePRO (PAREXEL) ERT/invivodata (diarypro/sitepro) AMC Health CRF Health (TrialMax) System Flexibility and Support ERT/invivodata (diarypro/sitepro) ClinPhone IVR ePRO (PAREXEL) Almac PHT Validation and Patient Compliance ERT/invivodata (diarypro/sitepro) OutcomeLogix (Oracle) Biomedical Systems (Michelangelo) ClinPhone IVR ePRO (PAREXEL) Sample Page Attributes Rated Highest Second Highest Third Highest Close Contenders Overall satisfaction Company A Company C Company F Company J Company E Company G Reasonableness of Cost Company B Company D Company E Company H Usability Company A Company B Company G Company E System/Device Integration Company B Company E Company A Company G Company F System Flexibility and Support Company A Company E Company G Company I Validation and Patient Compliance Company A Company B Company H Company E Service Provider Performance by Category ISR asked respondents to rate each eCOA/ePRO provider they have recently used across 21 different dimensions of performance. ISR’s methodology for doing so asks each user to rate the service’s performance vs. the user’s expectations for each dimension. Scores are assigned to ratings as follows: • Greatly exceeded my expectations: +3 • Somewhat exceeded my expectations: +1 • Met my expectations: 0 • Somewhat fell short of my expectations: -1 • Greatly fell short of my expectations: -3 ISR then organized these attributes into categories and produced an average score for each category. The chart below shows the first, second, and third highest rated companies by category as well as those companies that were close contenders. Company A and Company E appear in the top 4 in 5 of the 6 performance categories. Company B despite not being heavily used by respondents ranked in the top 2 in 4 of six categories. This suggests that in addition to Company B exceeding performance expectations by users, they may have opportunity for growth. Company A and Company E both have high performance scores but are also used more often than Company B. For sponsors, it may be worth exploring the services offered by Company B, particularly since one of the categories in which they lead is Reasonableness of Cost.
  • 7. www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 7 act with confidence Sample Page act with confidence EDC Provider Selection Criteria www.ISRreports.com ©2015 | EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 42 Contract Directly vs� Going through CRO for EDC Components Roughly half the time, sponsors contract directly with an EDC provider as opposed to going through the CRO� Moving forward, this figure is expected to increase by roughly 10 percentage points� Similarly, moving forward, CROs expect a decline in how often the sponsor almost always contracts through our organization (being the CRO)� Currently 52% of respondents from CROs say this, but in three years’ time, only 39% of CRO respondents expect this to be the case� “Currently, when your organization is using a CRO for a clinical study that has an EDC component, what percent of the time do you contract directly with an EDC provider as opposed to going through the CRO?” (Base=50; sponsors only) “Thinking three years into the future, when your organization is using a CRO for a clinical study that has an EDC component, what percent of the time will you contract directly with an EDC provider as opposed to going through the CRO?” (Base=48; sponsors only) 43% 52%
  • 8. www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 8 act with confidence Sample Page For full table of contents and additional sample pages, download the full preview from: www.isrreports.com/?p=5699
  • 9. www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 9 act with confidence Ordering Information Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services indus- tries.  With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise.    For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports. About Industry Standard Research Save on this, or any ISR report, by registering a free account Register now • Receive a $250 instant credit towards any ISR report • Earn 10% credit towards all future purchases • Receive advanced notifications on ISR’s latest reports and free resources For pricing and ordering information visit: www.isrreports.com/?p=5699
  • 10. www.ISRreports.com ©2015 | Preview of: EDC and eCOA/ePRO Market Dynamics and Service Provider Performance (2015) 10 act with confidence www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10 act with confidence www.ISRreports.com ©2015 | Preview of: Epithelial Ovarian Cancer: Disease and Pipeline Analysis 10 act with confidence www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10 act with confidence www.ISRreports.com ©2014 | Preview of: Benchmarking European Investigator Payments 10 act with confidence www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10 act with confidence The ISR Difference Custom-quality syndicated market research www.ISRreports.com ISR's Reports The Common Syndicated Reportvs. How confident are you? vs. DataCollection ISR's proprietary data collection tools and channels support fast, high quality data collection Struggle to recruit the right targets and enough of them vs. SampleSizes Robust sample sizes that instill confidence Often insufficient industry representation that leaves you defending results vs.vs. Research methods Mostly primary research; always appropriate for the topic One size fits all; usually publically available data vs.vs. Respondents Sophisticated screening ensures genuine decision-makers Undisclosed methodologies and respondent demographics vs.vs. Analysts Decades of experience means more insights that are immediately usable Junior analysts capable of reporting numbers